| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/28/2005 | US6911425 Integrin binding motif containing peptides and methods of treating skeletal diseases |
| 06/28/2005 | US6911227 Gels for encapsulation of biological materials |
| 06/28/2005 | US6911219 Compositions injectable via a catheter to form occlusive masses in a selected body region; highly dispersed in a liquid medium of given specific gravity; nonclumping in the delivery equipment during embolization |
| 06/28/2005 | US6911218 Microparticles of a free carboxyl group polymer and a free amino group drug, dissolving in acetone, acetonitrile, ethyl acetate, tetrahydrofuran, or glyme and atomizing in a nozzle to an ethanol or isopropanol dispersion |
| 06/28/2005 | US6911217 Controlled release bead, a method of producing the same and multiple unit formulation comprising it |
| 06/28/2005 | US6911216 Targeted delivery via biodegradable polymers |
| 06/28/2005 | US6911214 Containing lopinavir or its mixtures, comprising a sweetener, two or more flavoring agents menthol, peppermint, vanilla, cotton candy flavors, and flavor modifier such as sodium citrate, sodium chloride and citric acid |
| 06/28/2005 | US6911213 Pernasally absorbable insulin preparations |
| 06/28/2005 | US6911211 Pharmaceutical and cosmetic carrier or composition for topical application |
| 06/28/2005 | CA2402300C Fluorocarbon aerosol medicaments |
| 06/28/2005 | CA2317411C Controlled release delivery of peptide or protein |
| 06/28/2005 | CA2271196C Pharmaceutical compositions of hiv protease inhibitors with improved oral bioavailability |
| 06/28/2005 | CA2232604C Method for preserving infectious recombinant viruses, aqueous viral suspension and use as medicine |
| 06/28/2005 | CA2152280C Use of riluzole as a radiorestorer |
| 06/28/2005 | CA2138110C Cosmetic and/or dermatologic composition containing salicylic acid derivatives and process for their solubilization |
| 06/26/2005 | WO2005047217A1 Process for the preparation of 1-octene |
| 06/23/2005 | WO2005057163A2 Method to fabricate microcapsules from polymers and charged nanoparticles |
| 06/23/2005 | WO2005056708A2 Bioadhesive polymers with catechol functionality |
| 06/23/2005 | WO2005056648A1 Form of administration based on crosslinked hydrophilic polymers |
| 06/23/2005 | WO2005056641A1 Coordination complex of diaminocyclohexaneplatinum(ii) with block copolymer containing poly(carboxylic acid) segment and antitumor agent comprising the same |
| 06/23/2005 | WO2005056576A2 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 06/23/2005 | WO2005056506A1 Lutein concentrate |
| 06/23/2005 | WO2005056113A1 Compounds for the treatment of ocular dryness caused by photorefractive surgery |
| 06/23/2005 | WO2005056103A1 Method of treatment for undesired effect following transdermal or topical drug delivery |
| 06/23/2005 | WO2005056075A2 Transdermal system for sustained delivery of polypeptides |
| 06/23/2005 | WO2005056038A1 Pharmaceutical compositions and methods for insulin treatment |
| 06/23/2005 | WO2005056037A1 Metered dose inhalation preparations of proteins and peptides |
| 06/23/2005 | WO2005056029A1 The traditional chinese medicine preparation for treatment of tumour and method of making and using same |
| 06/23/2005 | WO2005056025A1 Methods and composition for transplantation of dopaminergic neurons for parkinson's disease |
| 06/23/2005 | WO2005056008A1 Intranasal compositions |
| 06/23/2005 | WO2005055993A2 Pharmaceutical preparation containing gabapentin |
| 06/23/2005 | WO2005055992A1 Device for dosing a product that is intended to be applied to the skin |
| 06/23/2005 | WO2005055991A1 Administration form based on cross-linked hydrophilic polymers |
| 06/23/2005 | WO2005055990A1 Hard capsules produced from water-dispersible copolymers of hydroxyalkyl (meth)acrylate, polyvinyl alcohol and/or polyvinylpyrrolidone |
| 06/23/2005 | WO2005055989A1 Drug-containing grains and solid preparation containing the grains |
| 06/23/2005 | WO2005055988A2 Microparticles |
| 06/23/2005 | WO2005055987A1 TASTE MASKED PHARMACEUTICAL COMPOSITIONS COMPRISING BITTER DRUG AND pH SENSITIVE POLYMER |
| 06/23/2005 | WO2005055986A1 Taste masked pharmaceutical composition comprising ph sensitive polymer |
| 06/23/2005 | WO2005055985A1 Metered dose inhalation preparations of therapeutic drugs |
| 06/23/2005 | WO2005055984A1 Method for preparation of salt aerosol with predefined concentration |
| 06/23/2005 | WO2005055983A2 Method of preparation of mixed phase co-crystals with active agents |
| 06/23/2005 | WO2005055982A2 An aqueous dispersion of hydrogel nanoparticles with inverse thermoreversible gelation |
| 06/23/2005 | WO2005055981A2 Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same |
| 06/23/2005 | WO2005055979A2 Ph triggerable polymeric particles or films containing a poly (beta-amino ester) |
| 06/23/2005 | WO2005055978A2 A method of engineering particles for use in the delivery of drugs via inhalation |
| 06/23/2005 | WO2005055977A2 Form of administration for controlling primary headaches |
| 06/23/2005 | WO2005055976A2 Powder containing low-molecular dextran and method for producing the same |
| 06/23/2005 | WO2005055975A2 Uv-stable semi-solid transdermal systems comprising a photosensitive active ingredient and a uv absorber |
| 06/23/2005 | WO2005055973A2 Endoparasiticidal agents for topical application |
| 06/23/2005 | WO2005055972A2 A drug delivery device and a method of producing it |
| 06/23/2005 | WO2005055971A1 Pharmaceutical effervescent formulation comprising amoxycillin and clavulanic acid |
| 06/23/2005 | WO2005055964A1 Moisture triggered sealed release system |
| 06/23/2005 | WO2005055955A2 DOSING METHODS FOR ß-D-2’,3’-DIDEOXY-2’,3’-DIDEHYDRO-5-FLUOROCYTIDINE ANTIVIRAL THERAPY |
| 06/23/2005 | WO2005055954A2 Pharmaceutical compounding systems and methods |
| 06/23/2005 | WO2005055949A2 Sustained release preparations composed of biocompatible complex microparticles |
| 06/23/2005 | WO2005055948A2 Epha2, epha4 and lmw-ptp and methods of treatment of hyperproliferative cell disorders |
| 06/23/2005 | WO2005055945A2 Mucoadhesive drug delivery devices and methods of making and using thereof |
| 06/23/2005 | WO2005055924A2 Skin adherent hydrogels |
| 06/23/2005 | WO2005055921A2 Compositions for treatment of ear disorders and methods of use thereof |
| 06/23/2005 | WO2005049787A9 Compositions and methods for in vitro sorting of molecular and cellular libraries |
| 06/23/2005 | WO2005046643A3 Method for drug loading in liposomes |
| 06/23/2005 | WO2005041977A3 Process for producing injectable gabapentin compositions |
| 06/23/2005 | WO2005041919A3 Medicamentously targeted local lipolysis |
| 06/23/2005 | WO2005039287A3 Formulation of a synergistic insecticidal composition as a cyclodextrin-complex |
| 06/23/2005 | WO2005037784A3 Crystalline form of gamma-aminobutyric acid analog |
| 06/23/2005 | WO2005027873A3 Therapeutic aminoglycoside-containing hydrogel nanoparticles |
| 06/23/2005 | WO2005018602A3 Method for the production of effervescent granules in a vacuum |
| 06/23/2005 | WO2005013945A3 Medicaments for inhalation comprising steroids and a betamimetic |
| 06/23/2005 | WO2005011652A3 Use of a vitamin d receptor activator or a vitamin d analog to treat kidney disease |
| 06/23/2005 | WO2004071538A3 Topical delivery of cosmetic agents |
| 06/23/2005 | WO2004070549A3 Separation of validated information and functions in a healthcare system |
| 06/23/2005 | WO2004056407A3 Biomedical devices with antimicrobial coatings |
| 06/23/2005 | US20050137592 Vessel sealing instrument |
| 06/23/2005 | US20050137583 Drug delivery device |
| 06/23/2005 | US20050137537 Implantable refillable and ported controlled release drug delivery device |
| 06/23/2005 | US20050137536 Microneedle with membrane |
| 06/23/2005 | US20050137405 Reacting o-chlorobenzaldehyde with an alkyl 4-(phthalimido)ethoxy)acetoacetate to yield alkyl 2-(o-chlorobenzylidene)-4-(2-phthalimidoethoxy)acetoacetate which upon reacting with an alkyl -3-aminocrotonate yields a phtahalimiamlodipine; good yields and purity; useful as reference standards or markers |
| 06/23/2005 | US20050137334 Composite nanospheres and their conjugates with biomolecules |
| 06/23/2005 | US20050137265 For treating gastroparesis; does not have to be taken with liquids which helps ensure proper dosage in patients with nausea |
| 06/23/2005 | US20050137264 Modafinil compositions |
| 06/23/2005 | US20050137262 Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses |
| 06/23/2005 | US20050137205 Antiinflammatory agents for treatment of skin disorders |
| 06/23/2005 | US20050137198 Stable hydrazalazine pharmaceutical compositions |
| 06/23/2005 | US20050137166 Use of cooling agents to relieve mild ocular irritation and enhance comfort |
| 06/23/2005 | US20050137148 treating an infectious disease associated with narrowing or obstruction of a body passageway by delivering to an external portion of the body passageway an antibiotic; infections such as pelvic inflammatory disease, urethritis, or tuberculosis |
| 06/23/2005 | US20050136247 Non-aqueous absorbent and use thereof |
| 06/23/2005 | US20050136128 Dry powders of metal-containing compounds |
| 06/23/2005 | US20050136122 Preparing and using crosslinked, water insoluble, hydrated hyaluronic acid gel particles; in vivo biostability and mechanical properties, usability; ease of injection through fine needles |
| 06/23/2005 | US20050136121 Melting lipid, dry mixing dry particles comprising filler and peptide; suspension; continuously coating; pseudoplastic and/or thixotropic properties; pouring or molding into a dosage form |
| 06/23/2005 | US20050136120 Intravenous pharmaceutical form of administration |
| 06/23/2005 | US20050136119 Liquid matrix containing drug, a first flavoring agent, and a plurality of particles comprising a second flavoring agent; adjusted color, flavor, sweetness, texture |
| 06/23/2005 | US20050136116 Thickener of hydroxyethyl cellulose, methyl cellulose, ethyl cellulose, hydroxypropyl cellulose, hydropropyl methyl cellulose, hydroxy ethyl methylcellulose, hydroxypropyl methylcellulose; and buffer of potassium or sodium phosphate; shelf life; no refrigeration |
| 06/23/2005 | US20050136115 Dry syrups maintain bioavailability; variety of polymorphic forms; co- or terpolymer coating of (meth)acrylate hydrophobic monomer, a diethylamino (meth)acrylate or vinylpyridine-type basic monomer, and a hydrophilic hydroxyalkyl (meth)acrylate monomer; microparticles dispersed; crystal growth inhibitors |
| 06/23/2005 | US20050136114 Acts as reverse enteric coating soluble in acidic stomach but insoluble at saliva pH; co- or terpolymer coating has (meth)acrylate hydrophobic monomer, a diethylamino (meth)acrylate or vinylpyridine-type basic monomer, and a hydrophilic hydroxyalkyl (meth)acrylate monomer; microparticles dispersed |
| 06/23/2005 | US20050136113 Dosage form comprising a semipermeable wall defining a cavity having an exit orifice; expandable layer; flow control agent; sustained release push delivery devices having high drug loading with minimized residue |
| 06/23/2005 | US20050136112 Oral medicament delivery system |
| 06/23/2005 | US20050136111 Novel composition and use |
| 06/23/2005 | US20050136110 In a matrix-forming, hydrophilic or hydrophobic polymer comprising a cellulose ether or ester of hydroxypropyl methyl cellulose, hydroxyethycellulose, hydroxypropycellulos, methycellulose, ethycellulose and/or carboxymethyl cellulose |
| 06/23/2005 | US20050136109 Oral extended release drug or veterinary composition in compressed tablet form comprising venlafaxine, or an enantiomeric form or water soluble salt thereof and a carboxyvinyl polymer such as Carbopol"; antidepressants, bioavailability |
| 06/23/2005 | US20050136108 Stepwise delivery of topiramate over prolonged period of time |